deltatrials
Unknown OBSERVATIONAL NCT03000335

Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk

Evaluation of ProALL microRNAs in Blood Specimen for Prediction of Acute Lymphoblastic Leukemia Relapse Risk

Sponsor: Curewize Health Ltd.

Conditions B-cell Acute Lymphoblastic Leukemia
Updated 15 times since 2017 Last updated: Jan 31, 2019 Started: Dec 31, 2016 Primary completion: May 31, 2020 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03000335, this observational or N/A phase trial focuses on B-cell Acute Lymphoblastic Leukemia and remains ongoing. Sponsored by Curewize Health Ltd., it has been updated 15 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Mar 2017 · 59 days · monthly snapshot~Mar 2017 – ~May 2017 · 2 months · monthly snapshot~May 2017 – ~Aug 2017 · 3 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshot~Mar 2019 – ~Nov 2020 · 20 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshot~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  4. Mar 2022 — Jul 2024 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

  5. Dec 2021 — Mar 2022 [monthly]

    Recruiting

▶ Show 10 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Recruiting

  2. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  3. Mar 2019 — Nov 2020 [monthly]

    Recruiting

  4. Jun 2018 — Mar 2019 [monthly]

    Recruiting

  5. May 2018 — Jun 2018 [monthly]

    Recruiting

  6. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  7. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  8. May 2017 — Aug 2017 [monthly]

    Recruiting NA

  9. Mar 2017 — May 2017 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  10. Jan 2017 — Mar 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Curewize Health Ltd.
Data source: Curewize Health Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations